MedPath

The Sleep Improving Effects of Orange Phenolics

Not Applicable
Completed
Conditions
Fatigue
Polyphenols
Sleep
Interventions
Dietary Supplement: Identical looking placebo
Dietary Supplement: Lozenge containing citrus flavonoid
Dietary Supplement: Lozenge containing citrus flavonoid formulation
Registration Number
NCT02209103
Lead Sponsor
Maastricht University Medical Center
Brief Summary

This study aims to determine whether a citrus flavonoid or a citrus flavonoid formulation can improve objective sleep duration and/or quality, and/or improve perceived sleep quality and feelings of rest.

Participants will complete a total of 9 test nights, which consist of sleeping with the sleep monitoring system after ingestion of the test product or a placebo, and filling out sleep-related questionnaires.

The study has a crossover design, meaning that all participants receive all three interventions (citrus flavonoid, citrus flavonoid formulation, placebo) three times, in a randomized order.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
77
Inclusion Criteria
  • Age 18-75
  • Non-smoking
  • Healthy
  • Lightly disturbed sleep for at least six months, on a regular basis
Exclusion Criteria
  • Severe sleep disorders (sleep apnea, restless legs syndrome)
  • An apparent cause for the sleep disorders (pain, etc.)
  • Clinically significant abnormal liver functioning
  • Clinically significant abnormal serum creatinine
  • BMI lower than 18 or higher than 30 kg/m2
  • Use of concomitant medications or supplements

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
PlaceboIdentical looking placeboPlacebo
Citrus flavonoidLozenge containing citrus flavonoidCitrus flavonoid
Citrus flavonoid formulationLozenge containing citrus flavonoid formulationCitrus flavonoid formulation
Primary Outcome Measures
NameTimeMethod
Sleep quality as assessed objectively by means of a portable sleep monitoring system (ZEO)9 test nights (up to 9 days)

• The primary endpoint for this study is the determination of sleep quality, as assessed objectively with the portable sleep monitoring system ZEO, which is based on EEG/EMG (electromyography) coupled with an automatic sleep phase classifier. Sleep stages are classified as deep sleep, light sleep, REM (rapid eye movement) sleep or awake. The sleep patterns of the participants after ingestion of the two different test products will be compared to each other and to placebo.

Secondary Outcome Measures
NameTimeMethod
Subjective sleep quality ratings and fitness, tiredness and cognitive ratings, obtained from questionnairesup to 9 days. Questionnaires are filled out the morning after every test night

Leeds Sleep Evaluation Questionnaire

Trial Locations

Locations (1)

Maastricht University Medical Center (MUMC)

🇳🇱

Maastricht, Netherlands

© Copyright 2025. All Rights Reserved by MedPath